Clinical Trial Update: Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition [Phase 2]

View source ↗

Summary

Biomed Industries has completed a Phase 2 trial of NA-931 in adults with obesity and at least one weight-related comorbidity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NA-931

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Weight Loss, Obesity | Phase 2 | Status: COMPLETED